Government of India is planning to ban the use of plastic or polyethylene terephthalate (PET) bottles for packaging pharmaceutical products like syrups and liquid orals. The authorities consider the bottles used in packaging ...
Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the market size of monoclonal antibody agents ...
By Sana Moosa As provider organizations mature toward implementation of accountable care organizations (ACOs), manufacturers of biopharmaceutical products will need to stay abreast of changes, set the stage for innovative partnership, and ...
googletag.cmd.push(function() { googletag.display('div-gpt-ddcad-1'); }); Faced with rising out-of-pocket costs and complex treatment plans and armed with new social media tools and more information, pharmaceutical customers are changing ...
The most-recognized anti-infective brand in North America is Cipro. The brand was most-recognized by 7 percent of physicians in a survey conducted by Brand Institute Inc. during the second quarter of 2013. Cipro, comprising ciprofloxacin, ...
Belgium-based FLUIDDA has developed proprietary functional respiratory imaging (FRI) technology that provides a unique entry point into personalized medicine for respiratory diseases. FRI reduces significantly the number of patients ...
Alsa Refinish, a California-based company, has process and utility patent applications in place for a medication delivery method. If successful, Alsa will hold patents for a device that delivers medications and herbal preparations ...
Tags: Alsa Refinish, Medication Delivery
Health R&D Spending Moves Slowly Upward, Driven by Industry, Philanthropy and Voluntary Health Associations Federal R&D Funding Remains "Woefully Inadequate" to Address Health Threats and Global Competitiveness ?Highlights: ?Overall ...
After declining in FY10-11,health-related research and development(R&D)spending in the U.S.increased by$4.3 billion(3.5%)in FY11-12,according to Truth and Consequences:Health R&D Spending in the U.S.(FY11-12),the 10th edition from ...
Tags: Health R&D Spending, R&D of Health
Elemica, a leading supply chain operating network provider for the process industries, announces that nine of the top ten companies listed on the ICIS Top 100 Chemical Companies annual ranking conduct commerce through Elemica's QuickLink ...
Tags: Construction, Decoration
Industry Veterans Bring 360o Insight to Developing Managed Market Solutions for Stakeholders HealthSTAR Communications, a leading healthcare communications company, today announced the formation of HEALTHSTAR Market Access, LLC, a ...
Biodel, a specialty pharmaceutical company, has announced a long-term supply agreement with Becton, Dickinson and Company, a medical technology company, for worldwide exclusive rights to the novel and proprietary BD Uniject SCF disposable ...
Tags: Biodel, Rescue Device
Eighteen medical communication companies (MCCs) received about $100 million from 13 pharmaceutical and one device company that released data in 2010, and all or most of the 18 MCCs were for profit, conducted continuing medical education ...
Tags: MCCs, Pharma, Medicine News
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. and partner, Banner Pharmacaps Inc. (a wholly-owned subsidiary of Patheon Inc.), have entered into a settlement and license agreement with Eisai Inc. ...
Tags: Mylan, Targretin Suit, Treatment of Cutaneous Manifestations
A collaborative pharmaceutical project focused on improving the pathway for developing paediatric formulations has been given the go-ahead after successfully securing an innovation grant. The UK-wide consortium, led by Astra Zeneca, ...